Allegro Ophthalmics, LLC Company Profile

00:09 EDT 21st March 2019 | BioPortfolio

With more than 100 years of combined experience in vision science and medicine, the leadership team at Allegro Ophthalmics, LLC is establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of wet age-related macular degeneration, diabetic retinopathy and diabetic macular edema, which together affect nearly six million Americans. Allegro Ophthalmics offers the potential to prevent vision loss for millions of people, while also liberating others from legal blindness to a much improved quality of life sustained by self-sufficient functional vision.

News Articles [5 Associated News Articles listed on BioPortfolio]

Global Ophthalmics Partnering 2012-2018: Deal trends, players and financials

LONDON, Oct. 2, 2018 /PRNewswire/ -- Global Ophthalmics Partnering 2012 to 2018 provides the full collection of Ophthalmics disease deals signed between the world's pharmaceutical Read more...

Eton raises $20.1mm via Series A financing

Eton Pharmaceuticals Inc. raised $20.1mm through its Series A financing of 6.9mm preferred shares at $3 each. The company is developing therapies using the FDA’s 505(b)(2) regulatory pathway. Eton i...

aseptic drying, biological manufacturing, parenthals, ophthalmics, lyophilization, formulation development

Provider of, aseptic, manufacturing, toll drug, manufacturing, prefilled syringes, lyophilized drugs, contract drug, development, formulation

Global Clinical Information System Market Data Survey Report 2025 [Report Updated: 01011970] Prices from USD $1500

SummaryThe global Clinical Information System market will reach Volume Million USD in 2018 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegional mar...

iChek Adds New Advisory Board Member

Recognized visionary expert added to expand company vision and strategic development iChek, a pioneer in the development of an active contact lens technology for glucos...

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [11 Associated Companies listed on BioPortfolio]

Allegro Ophthalmics, LLC

With more than 100 years of combined experience in vision science and medicine, the leadership team at Allegro Ophthalmics, LLC is establishing Integrin Peptide Therapy as the ...

Allegro Medical

Allegro Medical, member of the Scrip Companies family, is the country’s leading online medical supply store for durable medical equipment and medical supplies. Allegro...

Azura Ophthalmics Ltd.

Azura Ophthalmics is a clinical-stage biotechnology company headquartered in Tel Aviv-Yafo, Israel. Azura Ophthalmics is developing an innovative portfolio of compounds in combina...

Pfizer Ophthalmics

Pfizer Ophthalmics, a division of Pfizer Inc, is committed to preserving sight and eliminating preventable blindness. Pfizer Ophthalmics discovers, develops and provides leading treatments in ophthalm...

Allegro Diagnostics, Inc.

Allegro Diagnostics is a molecular diagnostics company focused on the development and commercialization of innovative genomic tests for the diagnosis, staging and informed treatme...

More Information about "Allegro Ophthalmics, LLC" on BioPortfolio

We have published hundreds of Allegro Ophthalmics, LLC news stories on BioPortfolio along with dozens of Allegro Ophthalmics, LLC Clinical Trials and PubMed Articles about Allegro Ophthalmics, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Allegro Ophthalmics, LLC Companies in our database. You can also find out about relevant Allegro Ophthalmics, LLC Drugs and Medications on this site too.

Quick Search


Relevant Topic

Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...

Corporate Database Quicklinks

Searches Linking to this Company Record